Alector (ALEC) Operating Leases (2019 - 2026)
Alector's (ALEC) quarterly Operating Leases came in at $13.7 million in Q2 2026, down 34.9% year-over-year from $21.0 million in Q2 2025, and down 12.44% quarter-over-quarter from $15.6 million in Q1 2026.
Analysis
Alector (ALEC) Operating Leases (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported Operating Leases for 8 consecutive years, with $13.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Leases fell 34.9% year-over-year to $13.7 million in Q2 2026; TTM through Jun 2026 was $13.7 million, a 34.9% decrease from a year earlier, with the FY2025 full-year figure at $17.5 million, down 28.26% from the prior year.
- Operating Leases was $13.7 million for Q2 2026 at Alector, down from $15.6 million in the prior quarter.
- Over five years, Operating Leases peaked at $38.8 million in Q1 2022 and troughed at $13.7 million in Q2 2026.
- A 5-year average of $27.4 million and a median of $28.3 million in 2024 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases fell 9.51% in 2022 and plunged 34.9% in 2026, its largest moves.
- Over 5 years, Operating Leases stood at $35.3 million in 2022, then retreated by 13.64% to $30.5 million in 2023, then slipped by 19.96% to $24.4 million in 2024, then dropped by 28.26% to $17.5 million in 2025, then slipped by 21.67% to $13.7 million in 2026.
- The last three Operating Leases figures came in at $13.7 million (Q2 2026), $15.6 million (Q1 2026), and $17.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.70 Mn |
| Mar 31, 2026 | 15.65 Mn |
| Dec 31, 2025 | 17.49 Mn |
| Sep 30, 2025 | 19.29 Mn |
| Jun 30, 2025 | 21.04 Mn |
| Mar 31, 2025 | 22.75 Mn |
| Dec 31, 2024 | 24.38 Mn |
| Sep 30, 2024 | 25.96 Mn |
| Jun 30, 2024 | 27.51 Mn |
| Mar 31, 2024 | 29.02 Mn |
| Dec 31, 2023 | 30.46 Mn |
| Sep 30, 2023 | 31.84 Mn |
| Jun 30, 2023 | 32.75 Mn |
| Mar 31, 2023 | 34.05 Mn |
| Dec 31, 2022 | 35.27 Mn |
| Sep 30, 2022 | 36.46 Mn |
| Jun 30, 2022 | 37.62 Mn |
| Mar 31, 2022 | 38.75 Mn |
| Dec 31, 2021 | 39.81 Mn |
| Sep 30, 2021 | 40.83 Mn |